Completed
A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)
NCT05656040
- Conditions
- Chronic Disease, Disease Attributes, End-stage Kidney Disease, +12 more
- Locations
-
- Velocity Clinical Research, New Smyrna Beach ( Site 0003) Edgewater, Florida, United States
- Advanced Pharma CR, LLC ( Site 0006) Miami, Florida, United States
- Genesis Clinical Research, LLC ( Site 0004) Tampa, Florida, United States
- Alliance for Multispecialty Research, LLC ( Site 0002) Knoxville, Tennessee, United States